Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L. reuteri DSM 17938 for Infantile Colic
NCT01541046Phase 2Completed
- Sponsor
- SickKids
- Start
- Nov 2011
- Primary completion
- Jun 2014
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in infantile colic comparing Biogaia L. reuteri DSM 17938 with Probiotic Placebo (2 arms). Primary endpoint: Mean change in crying time at 21 days. Started Nov 2011; status: completed.
02
Drugs
Lactobacillus reuteri DSM 17938
03
Conditions
infantile colic
Beyond the preview
Go deeper on NCT01541046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541046.